Funding for AFIRM

The AFIRM is managed and funded through the US Army Medical Research and Materiel Command (MRMC); with additional funding from the US Navy, Office of Naval Research; the US Air Force, Office of the Surgeon General; the National Institutes of Health; the Veterans Administration; and local public and private matching funding.

The AFIRM is composed of two independent research consortia working with the U.S. Army Institute of Surgical Research. One consortium is led by the Wake Forest Institute for Regenerative Medicine and the McGowan Institute for Regenerative Medicine in Pittsburgh (WFPC) while the other is led by Rutgers – the State University of New Jersey and the Cleveland Clinic (RCCC). Each consortium contains approximately 15 member organizations, which are mostly academic institutions.

In total, the two consortiums that make up AFIRM have $85 million in federal funding and $180 million in local and private funding dedicated – for a total of more than $250 million for the five-year project. AFIRM is moving toward becoming the United States military flagship medical research program dedicated to addressing the unprecedented challenges of caring for service members returning from Afghanistan and Iraq with multiple traumatic injuries.